Tara Gladwell, M.B.A.

President & Chief Operating Officer

Tara Gladwell, M.B.A.

President & Chief Operating Officer

As Rho’s President and Chief Operating Officer, Tara Gladwell combines her passion for clinical research and uncompromising drive for excellence to foster a corporate culture that attracts and retains the best talent in the industry.

During her almost 20 years at Rho, she has quite literally done it all. From leading full-service trials and NDA submissions to overseeing both Operations and Business Development, Ms. Gladwell has had the unique ability to experience Rho from many different perspectives. Utilizing her strong leadership skills, she continues to inspire growth and carry on Rho’s legacy of devoted customer service and impeccable results. Throughout, her expertise in business development strategy has ensured each new company objective remains true to Rho’s corporate purpose, vision and goals.

Always emphasizing the importance of a true partnership with our clients, Ms. Gladwell is passionate about building relationships and anticipating client needs, and has even picked up awards for her excellent customer and client service along the way.

Wired to thrive in the fast lane, Ms. Gladwell loves the excitement and quick pivots inherent to the drug development world. Starting with an idea or protocol, operationalizing it to meet client goals, and eventually ending with the satisfaction that comes with putting safe and effective treatments in the hands of those who need it – that’s what makes her tick.

Ms. Gladwell received her undergraduate degree in Biology from Guilford College and her MBA from Duke University Fuqua School of Business.

In her free time, Ms. Gladwell enjoys traveling with her husband and twin sons.